AI Verdict
GTHP has stronger fundamentals based on our AI analysis.
GTHP vs GTBP Fundamental Comparison
| Metric | GTHP | GTBP |
|---|---|---|
| Revenue | $767,000.0 | $0.0 |
| Net Income | $-3.2M | $-28.4M |
| Net Margin | -416.7% | N/A |
| ROE | N/A | -490.0% |
| ROA | -241.4% | -349.8% |
| Current Ratio | 0.09x | 3.50x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.04 | $-6.68 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GTHP vs GTBP: Frequently Asked Questions
Is GTHP or GTBP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GTHP has stronger fundamentals. GTHP is rated STRONG SELL (95% confidence) while GTBP is rated STRONG SELL (83% confidence). This is not investment advice.
How does GTHP compare to GTBP fundamentally?
GUIDED THERAPEUTICS INC has ROE of N/A vs GT Biopharma, Inc.'s -490.0%. Net margins are -416.7% vs N/A respectively.
Which stock pays higher dividends, GTHP or GTBP?
GTHP has a dividend yield of N/A or no dividend while GTBP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GTHP or GTBP for long term?
For long-term investing, consider that GTHP has STRONG SELL rating with 95% confidence, while GTBP has STRONG SELL rating with 83% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GTHP vs GTBP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GTHP vs GTBP, the AI consensus favors GTHP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.